FCD Type II exhibited the most extensive subtype-specific alterations, characterized by significant upregulation of AKT1, FGF2, IL1B, TLR4, HMGB1, VIM, MYD88, and TRAF6. The gene discussed is TRAF6; the disease is fleck corneal dystrophy.